Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nature ; 609(7926): 335-340, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35853476

RESUMEN

Adhesive pili assembled through the chaperone-usher pathway are hair-like appendages that mediate host tissue colonization and biofilm formation of Gram-negative bacteria1-3. Archaic chaperone-usher pathway pili, the most diverse and widespread chaperone-usher pathway adhesins, are promising vaccine and drug targets owing to their prevalence in the most troublesome multidrug-resistant pathogens1,4,5. However, their architecture and assembly-secretion process remain unknown. Here, we present the cryo-electron microscopy structure of the prototypical archaic Csu pilus that mediates biofilm formation of Acinetobacter baumannii-a notorious multidrug-resistant nosocomial pathogen. In contrast to the thick helical tubes of the classical type 1 and P pili, archaic pili assemble into an ultrathin zigzag architecture secured by an elegant clinch mechanism. The molecular clinch provides the pilus with high mechanical stability as well as superelasticity, a property observed for the first time, to our knowledge, in biomolecules, while enabling a more economical and faster pilus production. Furthermore, we demonstrate that clinch formation at the cell surface drives pilus secretion through the outer membrane. These findings suggest that clinch-formation inhibitors might represent a new strategy to fight multidrug-resistant bacterial infections.


Asunto(s)
Acinetobacter baumannii , Microscopía por Crioelectrón , Fimbrias Bacterianas , Chaperonas Moleculares , Acinetobacter baumannii/citología , Acinetobacter baumannii/ultraestructura , Elasticidad , Proteínas Fimbrias/química , Proteínas Fimbrias/metabolismo , Proteínas Fimbrias/ultraestructura , Fimbrias Bacterianas/química , Fimbrias Bacterianas/metabolismo , Fimbrias Bacterianas/ultraestructura , Chaperonas Moleculares/química , Chaperonas Moleculares/metabolismo , Chaperonas Moleculares/ultraestructura
2.
Structure ; 28(10): 1087-1100.e3, 2020 10 06.
Artículo en Inglés | MEDLINE | ID: mdl-32857965

RESUMEN

Acinetobacter baumannii is a Gram-negative bacterium primarily associated with hospital-acquired, often multidrug-resistant (MDR) infections. The ribosome-targeting antibiotics amikacin and tigecycline are among the limited arsenal of drugs available for treatment of such infections. We present high-resolution structures of the 70S ribosome from A. baumannii in complex with these antibiotics, as determined by cryoelectron microscopy. Comparison with the ribosomes of other bacteria reveals several unique structural features at functionally important sites, including around the exit of the polypeptide tunnel and the periphery of the subunit interface. The structures also reveal the mode and site of interaction of these drugs with the ribosome. This work paves the way for the design of new inhibitors of translation to address infections caused by MDR A. baumannii.


Asunto(s)
Acinetobacter baumannii/citología , Amicacina/química , Antibacterianos/química , Ribosomas/química , Tigeciclina/química , Acinetobacter baumannii/química , Sitios de Unión , Microscopía por Crioelectrón , Modelos Moleculares , Subunidades Ribosómicas/química , Subunidades Ribosómicas/metabolismo , Ribosomas/metabolismo
3.
Emerg Microbes Infect ; 9(1): 1149-1159, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32419626

RESUMEN

Bacterial persistence is one of the major causes of antibiotic treatment failure and the step stone for antibiotic resistance. However, the mechanism by which persisters arise has not been well understood. Maintaining a dormant state to prevent antibiotics from taking effect is believed to be the fundamental mechanistic basis, and persisters normally maintain an intact cellular structure. Here we examined the morphologies of persisters in Acinetobacter baumannii survived from the treatment by three major classes of antibiotics (i.e. ß-lactam, aminoglycoside, and fluoroquinolone) with microcopy and found that a fraction of enlarged spherical bacteria constitutes a major sub-population of bacterial survivors from ß-lactam antibiotic treatment, whereas survivors from the treatment of aminoglycoside and fluoroquinolone were less changed morphologically. Further studies showed that these spherical bacteria had completely lost their cell wall structures but could survive without any osmoprotective reagent. The spherical bacteria were not the viable-but-non-culturable cells and they could revive upon the removal of ß-lactam antibiotics. Importantly, these non-walled spherical bacteria also persisted during antibiotic therapy in vivo using Galleria mellonella as the infection model. Additionally, the combinational treatment on A. baumannii by ß-lactam and membrane-targeting antibiotic significantly enhanced the killing efficacy. Our results indicate that in addition to the dormant, structure intact persisters, the non-wall spherical bacterium is another important type of persister in A. baumannii. The finding suggests that targeting the bacterial cell membrane during ß-lactam chemotherapy could enhance therapeutic efficacy on A. baumannii infection, which might also help to reduce the resistance development of A. baumannii.


Asunto(s)
Acinetobacter baumannii/citología , Acinetobacter baumannii/efectos de los fármacos , Antibacterianos/farmacología , Viabilidad Microbiana/efectos de los fármacos , beta-Lactamas/farmacología , Animales , Membrana Celular/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple , Larva/efectos de los fármacos , Larva/microbiología , Pruebas de Sensibilidad Microbiana , Mariposas Nocturnas/efectos de los fármacos , Mariposas Nocturnas/microbiología
4.
Annu Rev Microbiol ; 73: 481-506, 2019 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-31206345

RESUMEN

Acinetobacter baumannii has emerged as an important nosocomial pathogen, particularly for patients in intensive care units and with invasive indwelling devices. The most recent clinical isolates are resistant to several classes of clinically important antibiotics, greatly restricting the ability to effectively treat critically ill patients. The bacterial envelope is an important driver of A. baumannii disease, both at the level of battling against antibiotic therapy and at the level of protecting from host innate immune function. This review provides a comprehensive overview of key features of the envelope that interface with both the host and antimicrobial therapies. Carbohydrate structures that contribute to protecting from the host are detailed, and mutations that alter these structures, resulting in increased antimicrobial resistance, are explored. In addition, protein complexes involved in both intermicrobial and host-microbe interactions are described. Finally we discuss regulatory mechanisms that control the nature of the cell envelope and its impact on host innate immune function.


Asunto(s)
Acinetobacter baumannii , Pared Celular/inmunología , Farmacorresistencia Bacteriana Múltiple/genética , Glucolípidos , Virulencia/genética , Acinetobacter baumannii/citología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/genética , Acinetobacter baumannii/inmunología , Adhesinas Bacterianas/genética , Adhesinas Bacterianas/metabolismo , Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/metabolismo , Biopelículas , Pared Celular/microbiología , Infección Hospitalaria , Proteínas Fimbrias/genética , Proteínas Fimbrias/metabolismo , Fimbrias Bacterianas/genética , Fimbrias Bacterianas/metabolismo , Genes Bacterianos , Glucolípidos/inmunología , Glucolípidos/metabolismo , Interacciones Microbiota-Huesped , Humanos , Inmunidad Innata , Canales Iónicos/genética , Canales Iónicos/metabolismo , Lipopolisacáridos/inmunología , Lipopolisacáridos/metabolismo , Interacciones Microbianas , Polisacáridos Bacterianos , Porinas/genética , Porinas/metabolismo , Sistemas de Secreción Tipo II/genética , Sistemas de Secreción Tipo II/metabolismo , Sistemas de Secreción Tipo VI/genética , Sistemas de Secreción Tipo VI/metabolismo , beta-Glucanos/inmunología , beta-Glucanos/metabolismo
5.
Med Clin (Barc) ; 152(7): 261-263, 2019 04 05.
Artículo en Inglés, Español | MEDLINE | ID: mdl-30146354

RESUMEN

INTRODUCTION AND OBJECTIVE: Contamination of sinks, even due to their underuse, is associated with the transmission of non-fermenting gram-negative bacilli (NFGNB) to patients in Augmented Care Units. After previous monitoring with environmental and patient samples, we now explore the impact of removing sinks from ICU cubicles on incidental isolations related to health care in bronchoaspirate samples of patients with invasive mechanical ventilation (IMV). MATERIAL AND METHODS: Quasi-experimental study, before-and-after, pre-intervention annuities April 2014-2016 and post-intervention April 2016-2017. Incidence densities per 1,000 days of IMV were studied, comparing by the exact method based on the binomial distribution and estimating the incidence density ratio. RESULTS: The incidence densities per 1,000 days of IMV of isolations by NFGNB in bronchoaspirate samples of the pre and post-intervention periods were 11.28 and 1.9, respectively. This implies a post-intervention incidence density 5.90 times lower than before (95% CI: 1.49-51.05, P=.003). CONCLUSIONS: Despite of the limitations of the design, the removal of sinks showed a reduction of the isolations.


Asunto(s)
Aparatos Sanitarios , Contaminación de Equipos , Bacterias Gramnegativas/aislamiento & purificación , Unidades de Cuidados Intensivos , Respiración Artificial , Acinetobacter baumannii/citología , Bacillus/aislamiento & purificación , Líquido del Lavado Bronquioalveolar/microbiología , Burkholderia cepacia/aislamiento & purificación , Chryseobacterium/aislamiento & purificación , Reservorios de Enfermedades/microbiología , Flavobacteriaceae/aislamiento & purificación , Humanos , Pseudomonas aeruginosa/aislamiento & purificación , Pseudomonas putida/aislamiento & purificación , Respiración Artificial/estadística & datos numéricos , Stenotrophomonas maltophilia/aislamiento & purificación , Factores de Tiempo
6.
J Am Chem Soc ; 140(19): 6137-6145, 2018 05 16.
Artículo en Inglés | MEDLINE | ID: mdl-29701966

RESUMEN

Antibiotic resistance of bacterial pathogens poses an increasing threat to the wellbeing of our society and urgently calls for new strategies for infection diagnosis and antibiotic discovery. The antibiotic resistance problem at least partially arises from extensive use of broad-spectrum antibiotics. Ideally, for the treatment of infection, one would like to use a narrow-spectrum antibiotic that specifically targets and kills the disease-causing strain. This is particularly important considering the commensal bacterial species that are beneficial and sometimes even critical to the health of a human being. In this contribution, we describe a phage display platform that enables rapid identification of peptide probes for specific bacterial strains. The phage library described herein incorporates 2-acetylphenylboronic acid moieties to elicit dynamic covalent binding to the bacterial cell surface. Screening of the library against live bacterial cells yields submicromolar and highly specific binders for clinical strains of Staphylococcus aureus and Acinetobacter baumannii that display antibiotic resistance. We further show that the identified peptide probes can be readily converted to bactericidal agents that deliver generic toxins to kill the targeted bacterial strain with high specificity. The phage display platform described here is applicable to a wide array of bacterial strains, paving the way to facile diagnosis and development of strain-specific antibiotics.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Péptidos/química , Staphylococcus aureus/efectos de los fármacos , Acinetobacter baumannii/química , Acinetobacter baumannii/citología , Antibacterianos/química , Sitios de Unión/efectos de los fármacos , Boranos/química , Ácidos Borónicos , Humanos , Pruebas de Sensibilidad Microbiana , Sondas Moleculares/química , Estructura Molecular , Staphylococcus aureus/química , Staphylococcus aureus/citología , Termodinámica
7.
Microbiology (Reading) ; 164(2): 217-220, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29300154

RESUMEN

The structures of capsular polysaccharides (CPSs) produced by different Acinetobacter baumannii strains have proven to be invaluable in confirming the role of specific genes in the synthesis of rare sugars through the correlation of genetic content at the CPS biosynthesis locus with sugars found in corresponding CPS structures. A module of four genes (rmlA, rmlB, vioA and vioB) was identified in the KL57 capsule biosynthesis gene cluster of A. baumannii isolate BAL_212 from Vietnam. These genes were predicted to direct the synthesis of 4-acetamido-4,6-dideoxy-d-glucose (N-acetylviosamine, d-Qui4NAc) and the K57 CPS was found to contain this monosaccharide. The K57 structure was determined and, in addition to d-Qui4NAc, included three N-acetylgalactosamine residues in the main chain, with a single glucose side branch. The KL57 gene cluster has not been found in any other A. baumannii genomes, but the rmlA-rmlB-vioA-vioB module is present in the KL119 gene cluster that would likely produce a d-Qui4NAc-containing CPS.


Asunto(s)
Acinetobacter baumannii/citología , Amino Azúcares/biosíntesis , Cápsulas Bacterianas/química , Familia de Multigenes/genética , Polisacáridos Bacterianos/química , Polisacáridos Bacterianos/genética , Acetilgalactosamina/biosíntesis , Acinetobacter baumannii/genética , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Genes Bacterianos/genética
8.
Sci Rep ; 7(1): 14216, 2017 10 27.
Artículo en Inglés | MEDLINE | ID: mdl-29079752

RESUMEN

We recently demonstrated a high rate of colistin dependence in Acinetobacter baumannii isolates exposed to colistin in vitro. In the present study, we obtained a colistin-resistant (H08-391R) and colistin-dependent mutant (H08-391D) from a colistin-susceptible parental strain (H08-391). We found that the colistin-dependent mutant converted into a stable colistin-resistant mutant (H08-391D-R) in vitro after four serial passages without colistin. H08-391D and H08-391D-R were both found to harbor defective lipid A, as indicated by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry analysis. Additionally, both contained an ISAba1 insertion in lpxC, which encodes a lipid A biosynthetic enzyme. Further, membrane potential measurements using the fluorescent dye 3,3'-diethyloxacarbocyanine iodide (DiOC2[3]) showed that the membrane potential of H08-391D and H08-391D-R was significantly decreased as compared to that of the parental strain, H08-391. Moreover, these mutant strains exhibited increased susceptibilities to antibiotics other than colistin, which may be attributed to their outer membrane fragility. Such phenomena were identified in other A. baumannii strains (H06-855 and its derivatives). Taken together, our study reveals that the colistin-dependent phenotype is a transient phenotype that allows A. baumannii to survive under colistin pressure, and can transition to the extremely resistant phenotype, even in an antibiotic-free environment.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Colistina/farmacología , Farmacorresistencia Bacteriana , Acinetobacter baumannii/citología , Acinetobacter baumannii/genética , Acinetobacter baumannii/metabolismo , Aminoácidos/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Lípido A/metabolismo , Mutación , Fenotipo , Análisis de Supervivencia , Transcriptoma/efectos de los fármacos
9.
Eur J Med Chem ; 101: 34-40, 2015 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-26114809

RESUMEN

The treatment of some infectious diseases can currently be very challenging since the spread of multi-, extended- or pan-resistant bacteria has considerably increased over time. On the other hand, the number of new antibiotics approved by the FDA has decreased drastically over the last 30 years. The main objective of this study was to investigate the activity of wasp peptides, specifically mastoparan and some of its derivatives against extended-resistant Acinetobacter baumannii. We optimized the stability of mastoparan in human serum since the specie obtained after the action of the enzymes present in human serum is not active. Thus, 10 derivatives of mastoparan were synthetized. Mastoparan analogues (guanidilated at the N-terminal, enantiomeric version and mastoparan with an extra positive charge at the C-terminal) showed the same activity against Acinetobacter baumannii as the original peptide (2.7 µM) and maintained their stability to more than 24 h in the presence of human serum compared to the original compound. The mechanism of action of all the peptides was carried out using a leakage assay. It was shown that mastoparan and the abovementioned analogues were those that released more carboxyfluorescein. In addition, the effect of mastoparan and its enantiomer against A. baumannii was studied using transmission electron microscopy (TEM). These results suggested that several analogues of mastoparan could be good candidates in the battle against highly resistant A. baumannii infections since they showed good activity and high stability.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Péptidos/farmacología , Venenos de Avispas/farmacología , Acinetobacter baumannii/citología , Acinetobacter baumannii/crecimiento & desarrollo , Antibacterianos/síntesis química , Antibacterianos/química , Supervivencia Celular , Colistina/farmacología , Relación Dosis-Respuesta a Droga , Células HeLa , Humanos , Péptidos y Proteínas de Señalización Intercelular , Pruebas de Sensibilidad Microbiana , Péptidos/síntesis química , Péptidos/química , Relación Estructura-Actividad , Venenos de Avispas/síntesis química , Venenos de Avispas/química
10.
Microb Pathog ; 74: 42-9, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25086432

RESUMEN

Filamentous hemagglutinin adhesins (FHA) are key factors for bacterial attachment and subsequent cell accumulation on substrates. Here an FHA-like Outer membrane (OM) adhesin of Acinetobacter baumannii ATCC19606(T) was displayed on Escherichia coli. The candidate autotransporter (AT) genes were identified in A. baumannii ATCC19606(T) genome. The exoprotein (FhaB1) and transporter (FhaC1) were produced independently within the same cell (FhaB1C1). The fhaC1 was mutated. In vitro adherence to epithelial cells of the recombinant FhaB1C1 and the mutant strains were compared with A. baumanni ATCC19606(T). A bivalent chimeric protein (K) composed of immunologically important portions of fhaB1 (B) and fhaC1 (C) was constructed. The mice vaccinated with chimeric protein were challenged with A. baumannii ATCC19606(T) and FhaB1C1 producing recombinant E. coli. Mutations in the fhaC1 resulted in the absence of FhaB1 in the OM. Expression of FhaB1C1 enhanced the adherence of recombinant bacteria to A546 bronchial cell line. The results revealed association of FhaB1 with bacterial adhesion and biofilm formation. Immunization with a combination of recombinant B and K proteins proved protective against A. baumanni ATCC19606(T). The findings may be applied in active and passive immunization strategies against A. baumannii.


Asunto(s)
Acinetobacter baumannii/fisiología , Adhesinas Bacterianas/metabolismo , Adhesión Bacteriana , Biopelículas/crecimiento & desarrollo , Hemaglutininas/metabolismo , Acinetobacter baumannii/citología , Acinetobacter baumannii/genética , Acinetobacter baumannii/inmunología , Adhesinas Bacterianas/genética , Adhesinas Bacterianas/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/genética , Antígenos Bacterianos/inmunología , Antígenos Bacterianos/metabolismo , Línea Celular , Células Epiteliales/microbiología , Escherichia coli/genética , Escherichia coli/aislamiento & purificación , Escherichia coli/metabolismo , Eliminación de Gen , Hemaglutininas/genética , Hemaglutininas/inmunología , Humanos , Ratones , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo
11.
Bioconjug Chem ; 25(4): 750-60, 2014 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-24635310

RESUMEN

The dry antibiotic development pipeline coupled with the emergence of multidrug resistant Gram-negative 'superbugs' has driven the revival of the polymyxin lipopeptide antibiotics. Polymyxin resistance implies a total lack of antibiotics for the treatment of life-threatening infections. The lack of molecular imaging probes that possess native polymyxin-like antibacterial activity is a barrier to understanding the resistance mechanisms and the development of a new generation of polymyxin lipopeptides. Here we report the regioselective modification of the polymyxin B core scaffold at the N-terminus with the dansyl fluorophore to generate an active probe that mimics polymyxin B pharmacologically. Time-lapse laser scanning confocal microscopy imaging of the penetration of probe (1) into Gram-negative bacterial cells revealed that the probe initially accumulates in the outer membrane and subsequently penetrates into the inner membrane and finally the cytoplasm. The implementation of this polymyxin-mimetic probe will advance the development of platforms for the discovery of novel polymyxin lipopeptides with efficacy against polymyxin-resistant strains.


Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/metabolismo , Diseño de Fármacos , Bacterias Gramnegativas/metabolismo , Imagen Molecular , Polimixina B/análogos & derivados , Polimixina B/metabolismo , Acinetobacter baumannii/citología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/crecimiento & desarrollo , Antibacterianos/química , Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Bacterias Gramnegativas/citología , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/crecimiento & desarrollo , Klebsiella pneumoniae/citología , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Microscopía Electrónica , Modelos Moleculares , Conformación Molecular , Polimixina B/química , Polimixina B/farmacología , Pseudomonas aeruginosa/citología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/crecimiento & desarrollo
12.
J Biophotonics ; 7(5): 287-94, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-23192934

RESUMEN

In this work we assessed the discriminatory ability of Fourier-transform Infrared Spectroscopy (FTIR) in 22 representative isolates from a collection of 318 carbapenem-hydrolyzing class D ß -lactamases (CHDL)-producing Acinetobacter spp. (5 hospitals; 2001-2008) previously characterized by DNA-based typing methods. FTIR spectra were acquired with a Bruker spectrometer and analyzed with support of several chemometric tools. The results showed that FTIR spectroscopy was able to distinguish the main CHDL-producing Acinetobacter baumannii lineages causing infection in Portugal, the ST103 carrying blaOXA-58 , ST98 carrying blaOXA-24/40 and ST92 carrying blaOXA-23 . Moreover, this study revealed distinctive phenotypic features of A. baumannii lineages causing infections that might justify different epidemic potential. Spectroscopy may arise as a low cost and easily to perform alternative for typing A. baumannii isolates.


Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/aislamiento & purificación , Antibacterianos/farmacología , Carbapenémicos/farmacología , Farmacorresistencia Bacteriana , Espectroscopía Infrarroja por Transformada de Fourier , Acinetobacter baumannii/citología , Células Clonales/efectos de los fármacos , Análisis Discriminante , Humanos , Análisis de los Mínimos Cuadrados
13.
Med Dosw Mikrobiol ; 65(2): 93-101, 2013.
Artículo en Polaco | MEDLINE | ID: mdl-24180136

RESUMEN

INTRODUCTION: The ability of growth of Acinetobacter baumannii as morphology colony variants have been observed. However, the importance of this phenomenon for its biology is not known. The aim of this study was to evaluate some properties of light and dark morphology colony variants. METHODS: Fifty two isolates were identified by MALDI TOF MS method (MALDI Biotyper, BRUKER). It was evaluated the adhesion to polystyrene and extracellular mucus production of morphology colony variants and its susceptibility to imipenem and meropenem by agar dilution method. RESULTS: Forty eight (92.3%) out of the 52 morphotypes Acinetobacter sp. were identified as A. baumannii, two (5.8%) as A. genomospecies 3, one as the A. calcoaceticus. Sixteen (61.0%) pairs of isolates showed differences in the similarity of the spectra to the spectra of reference strains in the MALDI-TOF MS method. Adhesion to polystyrene was observed in all dark and 92.3% light morphotypes. Extracellular slime was produced by 15 (57.7%) dark morphotypes, and 7 (26.9%) of clear. The differences in susceptibility to imipenem occurred in two (7.7%), and meropenem in three (11.5%) pairs of morphotypes. CONCLUSIONS: The results show diversity of biological properties of morphology colony variants of A. baumannii complex. Differences in the level of adhesion to polystyrene and slime production may indicate the importance of morphological differentiation in virulence of A. baumannii complex.


Asunto(s)
Acinetobacter baumannii/clasificación , Acinetobacter baumannii/fisiología , Antibacterianos/farmacología , Acinetobacter baumannii/citología , Acinetobacter baumannii/efectos de los fármacos , Adhesión Bacteriana , Imipenem/farmacología , Meropenem , Pruebas de Sensibilidad Microbiana , Especificidad de la Especie , Tienamicinas/farmacología
14.
PLoS One ; 8(8): e72968, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24023660

RESUMEN

Acinetobacterbaumannii has emerged as a dangerous opportunistic pathogen, with many strains able to form biofilms and thus cause persistent infections. The aim of the present study was to use high-throughput sequencing techniques to establish complete transcriptome profiles of planktonic (free-living) and sessile (biofilm) forms of A. baumannii ATCC 17978 and thereby identify differences in their gene expression patterns. Collections of mRNA from planktonic (both exponential and stationary phase cultures) and sessile (biofilm) cells were sequenced. Six mRNA libraries were prepared following the mRNA-Seq protocols from Illumina. Reads were obtained in a HiScanSQ platform and mapped against the complete genome to describe the complete mRNA transcriptomes of planktonic and sessile cells. The results showed that the gene expression pattern of A. baumannii biofilm cells was distinct from that of planktonic cells, including 1621 genes over-expressed in biofilms relative to stationary phase cells and 55 genes expressed only in biofilms. These differences suggested important changes in amino acid and fatty acid metabolism, motility, active transport, DNA-methylation, iron acquisition, transcriptional regulation, and quorum sensing, among other processes. Disruption or deletion of five of these genes caused a significant decrease in biofilm formation ability in the corresponding mutant strains. Among the genes over-expressed in biofilm cells were those in an operon involved in quorum sensing. One of them, encoding an acyl carrier protein, was shown to be involved in biofilm formation as demonstrated by the significant decrease in biofilm formation by the corresponding knockout strain. The present work serves as a basis for future studies examining the complex network systems that regulate bacterial biofilm formation and maintenance.


Asunto(s)
Acinetobacter baumannii/citología , Acinetobacter baumannii/genética , Biopelículas , Perfilación de la Expresión Génica , Regulación Bacteriana de la Expresión Génica , Plancton/genética , Análisis de Secuencia de ARN/métodos , 4-Butirolactona/análogos & derivados , 4-Butirolactona/biosíntesis , Acinetobacter baumannii/crecimiento & desarrollo , Acinetobacter baumannii/fisiología , Técnicas de Inactivación de Genes , Genes Bacterianos , Mutación/genética , Plancton/citología , ARN Mensajero/genética , Transcriptoma/genética , Regulación hacia Arriba/genética
15.
Anal Biochem ; 439(1): 37-43, 2013 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-23603065

RESUMEN

We report a simple, rapid, and reproducible fluorescence anisotropy-based method for measuring rate constants for acylation and deacylation of soluble penicillin binding protein (PBP) constructs by compounds in microtiter plates by means of competition with time-dependent acylation by BOCILLIN FL. The method is demonstrated by measuring the acylation rate constants of the PBP3 periplasmic domains from Pseudomonas aeruginosa and Acinetobacter baumannii by BOCILLIN FL, aztreonam, meropenem, and ceftazidime. The new method requires very little protein and can be completed in approximately 1h per compound. A set of BOCILLIN FL acylation progress curves collected over a range of competitor concentrations is fit globally to a kinetic model by numerical integration. First-order deacylation rate constants could also be measured, as demonstrated with a catalytically impaired mutant OXA-10 ß-lactamase.


Asunto(s)
Compuestos de Boro/metabolismo , Polarización de Fluorescencia/métodos , Proteínas de Unión a las Penicilinas/metabolismo , Penicilinas/metabolismo , Acinetobacter baumannii/citología , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Biocatálisis , Cinética , Proteínas de Unión a las Penicilinas/química , Periplasma/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Pseudomonas aeruginosa/citología
16.
PLoS One ; 8(3): e57730, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23483923

RESUMEN

Acinetobacter baumannii is an aerobic and gram-negative pathogenic bacterium that is resistant to most antibiotics. Recently, A. baumannii 1656-2 exhibited the ability to form biofilms under clinical conditions. In this study, global metabolite profiling of both planktonic and biofilm forms of A. baumannii 1656-2 was performed using high-resolution nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analysis to investigate the metabolic patterns leading to biofilm formation. Principal components analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) score plots showed a distinct separation between planktonic and biofilm cells. Metabolites including acetates, pyruvate, succinate, UDP-glucose, AMP, glutamate, and lysine were increasingly involved in the energy metabolism of biofilm formation. In particular, the ratio of N-acetyl-D-glucosamine (GlcNAc) to D-glucosamine (GlcNH2) was significantly higher during biofilm formation than under the planktonic condition. This study demonstrates that NMR-based global metabolite profiling of bacterial cells can provide valuable insight into the metabolic changes in multidrug resistant and biofilm-forming bacteria such as A. baumannii 1656-2.


Asunto(s)
Acinetobacter baumannii/citología , Acinetobacter baumannii/metabolismo , Biopelículas , Metabolómica/métodos , Plancton/metabolismo , Acinetobacter baumannii/crecimiento & desarrollo , Biopelículas/crecimiento & desarrollo , Análisis Discriminante , Análisis de los Mínimos Cuadrados , Espectroscopía de Resonancia Magnética , Análisis Multivariante , Plancton/citología , Análisis de Componente Principal
17.
PLoS One ; 8(12): e84361, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24391945

RESUMEN

Bacterial persistence is a feature that allows susceptible bacteria to survive extreme concentrations of antibiotics and it has been verified in a number of species, such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus spp., Mycobacterium spp. However, even though Acinetobacter baumannii is an important nosocomial pathogen, data regarding its persistence phenotype are still lacking. Therefore, the aim of this study was to evaluate the persistence phenotype in A. baumannii strains, as well as its variation among strains after treatment with polymyxin B and tobramycin. Stationary cultures of 37 polymyxin B-susceptible clinical strains of A. baumannii were analyzed for surviving cells after exposure to 15 µg/mL of polymyxin B for 6 h, by serial dilutions and colony counting. Among these, the 30 tobramycin-susceptible isolates also underwent tobramycin treatment at a concentration of 160 µg/mL and persister cells occurrence was evaluated equally. A high heterogeneity of persister cells formation patterns among isolates was observed. Polymyxin B-treated cultures presented persister cells corresponding from 0.0007% to 10.1% of the initial population and two isolates failed to produce detectable persister cells under this condition. A high variability could also be observed when cells were treated with tobramycin: the persister fraction corresponded to 0.0003%-11.84% of the pre-treatment population. Moreover, no correlation was found between persister subpopulations comparing both antibiotics among isolates, indicating that different mechanisms underlie the internal control of this phenotype. This is the first report of persister cells occurrence in A. baumannii. Our data suggest that distinct factors regulate the tolerance for unrelated antibiotics in this species, contrasting the multi-drug tolerance observed in other species (eg. dormancy-mediated tolerance). Supporting this observation, polymyxin B--an antibiotic that is believed to act on non-dividing cells as well--failed to eradicate persister cells in the majority of the isolates, possibly reflecting a disconnection between persistence and dormancy.


Asunto(s)
Acinetobacter baumannii/citología , Antibacterianos/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Viabilidad Microbiana/efectos de los fármacos , Fenotipo , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/crecimiento & desarrollo , Recuento de Colonia Microbiana , Polimixina B/farmacología , Especificidad de la Especie , Tobramicina/farmacología
18.
Biomed Environ Sci ; 25(6): 711-7, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23228842

RESUMEN

OBJECTIVE: Gas chromatography (GC) was used to investigate the cellular fatty acid (CFA) composition of 141 Acinetobacter baumannii and 32 A. calcoaceticus isolates from different locations in China and to find chemical markers to differentiate these two closely related bacteria. METHODS: Whole cell fatty acid methyl esters (FAMEs) were obtained by saponification, methylation, and extraction for GC analysis, followed by a standardized Microbial Identification System (MIS) analysis. RESULTS: All A. baumannii and A. calcoaceticus strains contained some major fatty acids, namely, 18:1 ω9c, 16:0, Sum In Feature 3, 12:0, 17:1ω8c, 3-OH-12:0, 17:0, Sum In Feature 2, 2-OH-12:0, and 18:0 compounds. Although most of the total CFAs are similar between A. baumannii and A. calcoaceticus strains, the ratios of two pairs of CFAs, i.e., Sum In Feature 3/18:1 ω9c versus 16:0/18:1 ω9c and Sum In Feature 3/18:1 ω9c versus unknown 12.484/18:1 ω9c fatty acids, could differentiate these two closely related bacteria. A. baumannii could be easily classified into two subgroups by plotting some ratios such as Sum In Feature 3/16:0 versus 17:0 and Sum In Feature 3/2-OH-12:0 versus 17:0 fatty acids. CONCLUSION: The ratios of some CFAs could be used as chemical markers to distinguish A. baumannii from A. calcoaceticus.


Asunto(s)
Acinetobacter baumannii/clasificación , Acinetobacter calcoaceticus/clasificación , Ácidos Grasos/metabolismo , Acinetobacter baumannii/citología , Acinetobacter baumannii/metabolismo , Acinetobacter calcoaceticus/citología , Acinetobacter calcoaceticus/metabolismo , Biomarcadores/metabolismo , Especificidad de la Especie
19.
J Appl Microbiol ; 113(4): 940-51, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22574702

RESUMEN

Contact angle analysis of cell surface hydrophobicity (CSH) describes the tendency of a water droplet to spread across a lawn of filtered bacterial cells. Colistin-induced disruption of the Gram-negative outer membrane necessitates hydrophobic contacts with lipopolysaccharide (LPS). We aimed to characterize the CSH of Acinetobacter baumannii using contact angles, to provide insight into the mechanism of colistin resistance. Contact angles were analysed for five paired colistin-susceptible and resistant Ac. baumannii strains. Drainage of the water droplet through bacterial layers was demonstrated to influence results. Consequently, measurements were performed 0·66s after droplet deposition. Colistin-resistant cells exhibited lower contact angles (38·8±2·8-46·8±1·3°) compared with their paired colistin-susceptible strains (40·7±3·0-48·0±1·4°; anova; P<0·05). Contact angles increased at stationary phase (50·3±2·9-61·5±2·5° and 47·4±2·0-50·8±3·2°, susceptible and resistant, respectively, anova; P<0·05) and in response to colistin 32mgl(-1) exposure (44·5±1·5-50·6±2·8° and 43·5±2·2-48·0±2·2°, susceptible and resistant, respectively; anova; P<0·05). Analysis of complemented strains constructed with an intact lpxA gene, or empty vector, highlighted the contribution of LPS to CSH. Compositional outer-membrane variations likely account for CSH differences between Ac. baumannii phenotypes, which influence the hydrophobic colistin-bacterium interaction. Important insight into the mechanism of colistin resistance has been provided. Greater consideration of contact angle methodology is necessary to ensure accurate analyses are performed.


Asunto(s)
Acinetobacter baumannii/citología , Antibacterianos/farmacología , Colistina/farmacología , Farmacorresistencia Bacteriana , Interacciones Hidrofóbicas e Hidrofílicas , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/genética , Membrana Celular/microbiología , Lipopolisacáridos/metabolismo , Microscopía de Fuerza Atómica , Fenotipo
20.
IUBMB Life ; 63(12): 1048-54, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22006724

RESUMEN

The genus Acinetobacter comprises a complex and heterogeneous group of bacteria, many of which are capable of causing a range of opportunistic, often catheter-related, infections in humans. However, Acinetobacter baumannii, as well as its close relatives belonging to genomic species 3 ("Acinetobacter pittii") and 13TU ("Acinetobacter nosocomialis"), are important nosocomial pathogens, often associated with epidemic outbreaks of infection, that are only rarely found outside of a clinical setting. These organisms are frequently pandrug-resistant and are capable of causing substantial morbidity and mortality in patients with severe underlying disease, both in the hospital and in the community. Several epidemic clonal lineages of A. baumannii have disseminated worldwide and seem to have a selective advantage over non-epidemic strains. The reasons for the success of these epidemic lineages remain to be elucidated, but could be related to the potential of these organisms to achieve very dynamic reorganization and rapid evolution of their genome, including the acquisition and expression of additional antibiotic resistance determinants, under fluctuating environmental and selective conditions.


Asunto(s)
Infecciones por Acinetobacter/epidemiología , Acinetobacter baumannii/patogenicidad , Acinetobacter/clasificación , Enfermedades Transmisibles Emergentes/epidemiología , Infección Hospitalaria/epidemiología , Brotes de Enfermedades/estadística & datos numéricos , Acinetobacter/citología , Acinetobacter/genética , Acinetobacter/patogenicidad , Infecciones por Acinetobacter/microbiología , Infecciones por Acinetobacter/mortalidad , Acinetobacter baumannii/citología , Acinetobacter baumannii/genética , Acinetobacter baumannii/aislamiento & purificación , Infección Hospitalaria/microbiología , Infección Hospitalaria/mortalidad , Salud Global , Humanos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...